Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, November 24, 2025

Neutrophil-to-Albumin Ratio Predicts Stroke-Associated Pneumonia in Patients with Intracerebral Hemorrhage

 Your competent? doctor didn't come up with a solution to the Netrophil to Albumin problem from this earlier research, right? So, you DON'T have a functioning stroke doctor, do you?

And your incompetent? doctor didn't come up with a solution to prevent pneumonia even after knowing about it for years! 

  • 11% Stroke-associated pneumonia (15 posts to Octor 2020)


  • So you described a problem; WHAT THE FUCK IS THE SOLUTION? No solution, useless research, I'd fire you all.

    The latest here:

    Neutrophil-to-Albumin Ratio Predicts Stroke-Associated Pneumonia in Patients with Intracerebral Hemorrhage

    Authors Wan JLiu YYuan XFan SXiao YFang FZhang Y

    Received 27 January 2025

    Accepted for publication 1 July 2025

    Published 11 August 2025 Volume 2025:18 Pages 10835—10843

    DOI https://doi.org/10.2147/JIR.S519664

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 4

    Editor who approved publication: Dr Adam Bachstetter

     Jun Wan,1,* Yuyang Liu,1,* Xiang Yuan,2 Shijie Fan,1 Yangchun Xiao,3 Fang Fang,2 Yu Zhang3

    1Center for Evidence-Based Medicine, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, People’s Republic of China; 2Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China; 3Department of Neurosurgery, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, People’s Republic of China

    *These authors contributed equally to this work

    Correspondence: Yu Zhang, Department of Neurosurgery, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, People’s Republic of China, Tel +8618113034616, Email zhangyu1057@cdu.edu.cn

    Background and Aim: Pneumonia is a significant complication that negatively impacts outcomes in patients with intracerebral hemorrhage (ICH). Identifying reliable biomarkers for predicting such infections is crucial for timely intervention and improving patient management. This study aims to evaluate the predictive value of neutrophil-to-albumin Ratio (NAR)for pneumonia in patients undergoing surgical intervention for ICH.
    Methods: This was a retrospective multicenter cohort study conducted at four tertiary hospitals. A total of 8016 patients diagnosed with spontaneous intracerebral hemorrhage (ICH) between were included. The neutrophil-to-albumin ratio (NAR) was calculated within 24 hours of admission. Logistic regression models, receiver operating characteristic (ROC) curves, and reclassification metrics (C-index, IDI, cNRI) were used to evaluate the association between NAR and the risk of pneumonia. The primary outcome was pneumonia.
    Results: A total of 8016 ICH patients were included in this study. Among them, 3921 patients (48.9%) had pneumonia. There was an association between NAR levels and pneumonia (OR = 1.81, 95% CI: 1.69– 1.94, p < 0.001). After adjustment, the results remained significant (adjusted OR = 1.62, 95% CI: 1.51– 1.75, p < 0.001). Compared to patients in the Low Group (NAR ≤ 0.21), those in the High Group (NAR > 0.21) had a higher long-term mortality risk (OR = 2.95, 95% CI: 2.68– 3.24, p < 0.001; adjusted OR = 1.99, 95% CI: 1.79– 2.21, p < 0.001). Additionally, the predictive performance of NAR for pneumonia was also significant (area under the ROC curve [95% CI] 0.663 [0.651– 0.675]; p < 0.001).
    Conclusion: Higher NAR is independently associated with pneumonia in patients with ICH. The early prediction of pneumonia using the simple biomarker NAR is feasible.

    No comments:

    Post a Comment